In March 2022, the French pharmaceutical group Sanofi paid some 150 million U.S. dollars upfront in the course of its licensing deal with American-based biotech company IGM Biosciences. Back in August 2020, the company also paid around 3.68 billion U.S. dollars upfront for its acquisition of biotech company Principia. This statistic illustrates the upfront payments made by Sanofi in select acquisition and licensing deals worldwide from December 2019 to March 2022.
Upfront payments by Sanofi in select acquisition and licensing deals between December 2019 and March 2022
(in million U.S. dollars)
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Evaluate Vantage. (March 29, 2022). Upfront payments by Sanofi in select acquisition and licensing deals between December 2019 and March 2022 (in million U.S. dollars) [Graph]. In Statista. Retrieved December 21, 2024, from https://www.statista.com/statistics/1300091/sanofi-expenditure-acquisition-licensing-deals-worldwide/
Evaluate Vantage. "Upfront payments by Sanofi in select acquisition and licensing deals between December 2019 and March 2022 (in million U.S. dollars)." Chart. March 29, 2022. Statista. Accessed December 21, 2024. https://www.statista.com/statistics/1300091/sanofi-expenditure-acquisition-licensing-deals-worldwide/
Evaluate Vantage. (2022). Upfront payments by Sanofi in select acquisition and licensing deals between December 2019 and March 2022 (in million U.S. dollars). Statista. Statista Inc.. Accessed: December 21, 2024. https://www.statista.com/statistics/1300091/sanofi-expenditure-acquisition-licensing-deals-worldwide/
Evaluate Vantage. "Upfront Payments by Sanofi in Select Acquisition and Licensing Deals between December 2019 and March 2022 (in Million U.S. Dollars)." Statista, Statista Inc., 29 Mar 2022, https://www.statista.com/statistics/1300091/sanofi-expenditure-acquisition-licensing-deals-worldwide/
Evaluate Vantage, Upfront payments by Sanofi in select acquisition and licensing deals between December 2019 and March 2022 (in million U.S. dollars) Statista, https://www.statista.com/statistics/1300091/sanofi-expenditure-acquisition-licensing-deals-worldwide/ (last visited December 21, 2024)
Upfront payments by Sanofi in select acquisition and licensing deals between December 2019 and March 2022 (in million U.S. dollars) [Graph], Evaluate Vantage, March 29, 2022. [Online]. Available: https://www.statista.com/statistics/1300091/sanofi-expenditure-acquisition-licensing-deals-worldwide/
